DENVER, Nov. 26, 2018 (GLOBE NEWSWIRE) -- BioScrip, Inc. (NASDAQ: BIOS) ("BioScrip" or the "Company"), the largest independent national provider of infusion and home care management solutions, today announced that the Company will host an Analyst and Investor Day on Thursday, December 6, 2018 in Reston, Virginia.
Daniel E. Greenleaf, President and Chief Executive Officer, will provide an update of the Company’s strategy and business, followed by a fireside chat with members of BioScrip’s executive management team. Presentations will begin at 10:30 am ET and conclude between 12:00 pm and 12:30 pm ET.
A live webcast of the event and copies of the materials presented will be accessible via the Company's investor relations website at https://investors.bioscrip.com/ or through the following link: https://event.webcasts.com/starthere.jsp?ei=1222421&tp_key=8818005a06.
Following management’s presentations, attendees will tour one of BioScrip’s “Branches of the Future” in nearby Chantilly, Virginia.
Attendance is by invitation only as space for the event is limited. Institutional investors and analysts interested in attending are encouraged to contact Kalle Ahl of The Equity Group at 212-836-9614 or at kahl@equityny.com.
About BioScrip, Inc.
BioScrip, Inc. is the largest independent national provider of infusion and home care management solutions, with approximately 2,100 teammates and nearly 70 service locations across the U.S. BioScrip partners with physicians, hospital systems, payors, pharmaceutical manufacturers and skilled nursing facilities to provide patients access to post-acute care services. BioScrip operates with a commitment to bring customer-focused pharmacy and related healthcare infusion therapy services into the home or alternate-site setting. By collaborating with the full spectrum of healthcare professionals and the patient, BioScrip provides cost-effective care that is driven by clinical excellence, customer service, and values that promote positive outcomes and an enhanced quality of life for those it serves.
Investor Contacts:
| Stephen Deitsch | Kalle Ahl, CFA |
| Chief Financial Officer & Treasurer | The Equity Group |
| T: (720) 697-5200 | T: (212) 836-9614 |
| stephen.deitsch@bioscrip.com | kahl@equityny.com |